Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.45−0.09 (-0.94%)
Close on Nov 13, 2026Market cap $843.86MP/E –Yield –
Syndax Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Syndax Pharmaceuticals's enterprise value was $651.12M on Nov 11, 2026, against $1.63B a year earlier. Over the last 5 years it ranged from $417.25M to $1.99B, with a median of $1.10B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $651.12M | -62.4% |
| 2025 | Dec 31, 2025 | $1.73B | +133.8% |
| 2024 | Dec 31, 2024 | $741.64M | -35.0% |
| 2023 | Dec 29, 2023 | $1.14B | -4.3% |
| 2022 | Dec 30, 2022 | $1.19B | +42.0% |
| 2021 | Dec 31, 2021 | $839.62M | +21.1% |
| 2020 | Dec 31, 2020 | $693.52M | +317.6% |
| 2019 | Dec 31, 2019 | $166.06M | +852.7% |
| 2018 | Dec 31, 2018 | $17.43M | -76.7% |
| 2017 | Dec 29, 2017 | $74.87M | +406.5% |
| 2016 | Dec 30, 2016 | $14.78M | – |
See a number that looks wrong?